- RCS treatment
- 1. радиопоглощающее покрытие2. применение средств уменьшения (радиолокационной) эффективной поверхности рассеяния
Авиасловарь. М.А.Левин. 2004.
Авиасловарь. М.А.Левин. 2004.
Melamine — This article is about the chemical compound. For the plastic also called melamine , see melamine resin. Melamine … Wikipedia
Copper extraction techniques — This article is about historical production methods. For modern methods, see Flash smelting. The Chino open pit copper mine in New Mexico … Wikipedia
Tetrahydrocannabinol — THC redirects here. For other uses, see THC (disambiguation). Tetrahydrocannabinol (THC) … Wikipedia
Nabilone — Systematic (IUPAC) name (6aR,10aR) rel 1 hydroxy 6,6 dimethyl 3 (2 methyloctan 2 yl) Clinical data AHFS/ … Wikipedia
Palmitoylethanolamide — IUPAC name N (2 hydroxyethyl)hexadecanamide … Wikipedia
Paracetamol — Acetaminophen Systematic (IUPAC) name … Wikipedia
Controversies surrounding Silvio Berlusconi — Silvio Berlusconi is an Italian media mogul and former Prime Minister of Italy, owning the largest broadcasting company in the country, Mediaset, his promises to sell off his personal assets, to avoid conflicts of interest, were unfulfilled, this … Wikipedia
Cannabis (drug) — Marijuana redirects here. For other uses, see Marijuana (disambiguation). For the plant genus, see Cannabis. Cannabis … Wikipedia
Дизайнерские наркотики — (от англ. to design проектировать, разрабатывать) психоактивные вещества, разрабатываемые с целью обхода действующего законодательства, синтетические заменители какого либо натурального вещества, полностью воспроизводящие… … Википедия
Effects of cannabis — Short term effects of cannabis Classification and external resources ICD 10 F12.0 The effects of cannabis are caused by cannabinoids, most notably tetrahydrocannabinol (THC). Cannabis has both psychological and physiological effects on the human… … Wikipedia
Cannabinoid receptor antagonist — The discovery of the endogenous cannabinoid system led to the development of CB1 receptor antagonists. The first cannabinoid receptor antagonist, rimonabant, was described in 1994. Rimonabant blocks the CB1 receptor selectively and it has been… … Wikipedia